Clinical investigation of a new broncholyticum--decloxizine--as compared with franol and placebo treatment.
D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004809:Ephedrine / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D004987:Ethers / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010634:Phenobarbital / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D013147:Spirometry; D013806:Theophylline / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D004987:Ethers; D006634:Histamine H1 Antagonists; D010879:Piperazines; D010919:Placebos; D000431:Ethanol; D013806:Theophylline; D004809:Ephedrine; D010634:Phenobarbital